Concept explainers
To review:
(a) The evidence that suggests that the evolution of the drug-resistant strain of the bacterium happened within the patient.
(b) The fitness rate of the rpoB (Beta subunit of ribose
Introduction:
Tuberculosis is a disease of the respiratory tract that is caused by Mycobacterium tuberculosis. A patient with tuberculosis was treated with rifampin antibiotic and the infection was cleared in 10 months. Two months later, the patient was readmitted and was treated with a variety of different antibiotics including rifampin, but dies because of respiratory failure because the antibiotic was not effective on the mutant bacteria mutated for rpoB gene. The
Want to see the full answer?
Check out a sample textbook solutionChapter 25 Solutions
Biological Science
- "On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient" ABSTRACT The rapid emergence of bacterial strains resistant to multiple antibiotics is posing a growing public health risk. The mechanisms underlying the rapid evolution of drug resistance are, however, poorly understood. The heterogeneity of the environments in which bacteria encounter antibiotic drugs could play an important role. E.g., in the highly compartmentalized human body, drug levels can vary substantially between different organs and tissues. It has been proposed that this could facilitate the selection of resistance mutants, and recent experiments support this. To study the role of spatial heterogeneity in the evolution of drug resistance, we present a quantitative model describing an environment subdivided into relatively isolated compartments with various antibiotic concentrations, in which bacteria evolve under the stochastic processes of proliferation, migration, mutation and…arrow_forwardExplain the process of genome reduction in endosymbiont in good detail. You may use one of the examples in McCutcheon & Moran 2012 (Extreme genome reduction in symbiotic bacteria, Nat. Rev. Microbiol. Doi: 10.1038/nrmicro2670) for your answer.arrow_forwardHow can RNA sequencing (RNA-Seq) and Mirccorays in Transcriptome analysis find disease genes? Please lay out the answer in steps and explain them.arrow_forward
- This is a research article title "On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient". Full article text: Hermsen, R., Deris, J. B., & Hwa, T. (2012). On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proceedings of the National Academy of Sciences, 109(27), 10775–10780. doi:10.1073/pnas.1117716109 QUESTION: What are your thoughts in the article's title? Discuss you answer in Biology manner.arrow_forwardSome advocate stockpiling the drug Tamiflu in the event of an influenza pandemic. Others point out that wealthy, Western nations would have an unfair advantage because developing nations (where the pandemic is most likely to start) would not have access to this expensive antiviral. Furthermore, some fear that indiscriminate use of the drug would promote the evolution of resistant flu strains. Given these caveats, do you think developed nations should stockpile Tamiflu for the protection and treatment of their citizens? Explain your answerarrow_forwardRESEARCH ARTICLE TITLE: "On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient" Full Article Reseach: Hermsen, R., Deris, J. B., & Hwa, T. (2012). On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proceedings of the National Academy of Sciences, 109(27), 10775–10780. doi:10.1073/pnas.1117716109 QUESTION: 1. In biological/science manner, what are your comments on how the authors constructed their ARTICLE/RESEACH TITLE (see article).arrow_forward
- What is the endosymbiotic theory? Discuss two lines of evidence that support the theory.arrow_forward"On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient" The rapid emergence of bacterial strains resistant to multiple antibiotics is posing a growing public health risk. The mechanisms underlying the rapid evolution of drug resistance are, however, poorly understood. The heterogeneity of the environments in which bacteria encounter antibiotic drugs could play an important role. E.g., in the highly compartmentalized human body, drug levels can vary substantially between different organs and tissues. It has been proposed that this could facilitate the selection of resistance mutants, and recent experiments support this. To study the role of spatial heterogeneity in the evolution of drug resistance, we present a quantitative model describing an environment subdivided into relatively isolated compartments with various antibiotic concentrations, in which bacteria evolve under the stochastic processes of proliferation, migration, mutation and death.…arrow_forward"On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient" The rapid emergence of bacterial strains resistant to multiple antibiotics is posing a growing public health risk. The mechanisms underlying the rapid evolution of drug resistance are, however, poorly understood. The heterogeneity of the environments in which bacteria encounter antibiotic drugs could play an important role. E.g., in the highly compartmentalized human body, drug levels can vary substantially between different organs and tissues. It has been proposed that this could facilitate the selection of resistance mutants, and recent experiments support this. To study the role of spatial heterogeneity in the evolution of drug resistance, we present a quantitative model describing an environment subdivided into relatively isolated compartments with various antibiotic concentrations, in which bacteria evolve under the stochastic processes of proliferation, migration, mutation and death.…arrow_forward
- "On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient" The rapid emergence of bacterial strains resistant to multiple antibiotics is posing a growing public health risk. The mechanisms underlying the rapid evolution of drug resistance are, however, poorly understood. The heterogeneity of the environments in which bacteria encounter antibiotic drugs could play an important role. E.g., in the highly compartmentalized human body, drug levels can vary substantially between different organs and tissues. It has been proposed that this could facilitate the selection of resistance mutants, and recent experiments support this. To study the role of spatial heterogeneity in the evolution of drug resistance, we present a quantitative model describing an environment subdivided into relatively isolated compartments with various antibiotic concentrations, in which bacteria evolve under the stochastic processes of proliferation, migration, mutation and death.…arrow_forward"On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient" The rapid emergence of bacterial strains resistant to multiple antibiotics is posing a growing public health risk. The mechanisms underlying the rapid evolution of drug resistance are, however, poorly understood. The heterogeneity of the environments in which bacteria encounter antibiotic drugs could play an important role. E.g., in the highly compartmentalized human body, drug levels can vary substantially between different organs and tissues. It has been proposed that this could facilitate the selection of resistance mutants, and recent experiments support this. To study the role of spatial heterogeneity in the evolution of drug resistance, we present a quantitative model describing an environment subdivided into relatively isolated compartments with various antibiotic concentrations, in which bacteria evolve under the stochastic processes of proliferation, migration, mutation and death.…arrow_forward"On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient" The rapid emergence of bacterial strains resistant to multiple antibiotics is posing a growing public health risk. The mechanisms underlying the rapid evolution of drug resistance are, however, poorly understood. The heterogeneity of the environments in which bacteria encounter antibiotic drugs could play an important role. E.g., in the highly compartmentalized human body, drug levels can vary substantially between different organs and tissues. It has been proposed that this could facilitate the selection of resistance mutants, and recent experiments support this. To study the role of spatial heterogeneity in the evolution of drug resistance, we present a quantitative model describing an environment subdivided into relatively isolated compartments with various antibiotic concentrations, in which bacteria evolve under the stochastic processes of proliferation, migration, mutation and death.…arrow_forward
- Human Anatomy & Physiology (11th Edition)BiologyISBN:9780134580999Author:Elaine N. Marieb, Katja N. HoehnPublisher:PEARSONBiology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStaxAnatomy & PhysiologyBiologyISBN:9781259398629Author:McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa StouterPublisher:Mcgraw Hill Education,
- Molecular Biology of the Cell (Sixth Edition)BiologyISBN:9780815344322Author:Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter WalterPublisher:W. W. Norton & CompanyLaboratory Manual For Human Anatomy & PhysiologyBiologyISBN:9781260159363Author:Martin, Terry R., Prentice-craver, CynthiaPublisher:McGraw-Hill Publishing Co.Inquiry Into Life (16th Edition)BiologyISBN:9781260231700Author:Sylvia S. Mader, Michael WindelspechtPublisher:McGraw Hill Education